Population Health and Cost-Effectiveness Implications of a “Treat All” Recommendation for HCV: A Review of the Model-Based Evidence

by Lauren E. Cipriano, Jeremy D. Goldhaber-Fiebert
Published 2018-05-01

Cost-effectiveness analysis of risk-factor guided and birth-cohort screening for chronic hepatitis C infection in the United States.

by Shan Liu, Lauren E Cipriano, Mark Holodniy, Jeremy D Goldhaber-Fiebert
Published 2013-01-01

Impact of university re-opening on total community COVID-19 burden.

by Lauren E Cipriano, Wael M R Haddara, Gregory S Zaric, Eva A Enns
Published 2021-01-01

Chronic kidney disease of non-traditional causes and proposed risk factors prevalence in hemodialysis patients from southwest Guatemala

by T. Laux, J. Barnoya, V. Sanchez, A. Lucas, E. Herrera, E. Cipriano, M. Rothstein
Published 2015-03-01

Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users.

by Lauren E Cipriano, Gregory S Zaric, Mark Holodniy, Eran Bendavid, Douglas K Owens, Margaret L Brandeau
Published 2012-01-01

Joint involvement in patients affected by systemic lupus erythematosus: application of the swollen to tender joint count ratio

by E. Cipriano, F. Ceccarelli, L. Massaro, F. R. Spinelli, C. Alessandri, C. Perricone, G. Valesini, F. Conti
Published 2015-09-01

Post-mortem 7 Tesla MRI detection of white matter hyperintensities: A multidisciplinary voxel-wise comparison of imaging and histological correlates

by Austyn D. Roseborough, Kristopher D. Langdon, Robert Hammond, Lauren E. Cipriano, Stephen H. Pasternak, Shawn N. Whitehead, Ali R. Khan
Published 2020-01-01

Anti-D4GDI antibodies activate platelets in vitro: a possible link with thrombocytopenia in primary antiphospholipid syndrome

by C. Barbati, L. Stefanini, T. Colasanti, E. Cipriano, A. Celia, G. Gabriele, M. Vomero, F. Ceccarelli, F. R. Spinelli, A. Finucci, M. Speziali, G. Orso, D. P. E. Margiotta, F. Conti, F. Violi, A. Afeltra, G. Valesini, C. Alessandri
Published 2019-07-01